Table 3. Propensity-score matched CABG/Valve group.

Patient Characteristic	Pre-Implementation	Post-Implementation	P-Value
	747	747
Age at Procedure	67.3 (59.4, 74.9)	68.7 (60.9, 74.6)	0.16
Female Gender, n(%)	165 (22.1%)	157 (21.0%)	0.61
Race, n(%)			0.98
White	409 (54.8%)	410 (54.9%)
Black	21 (2.8%)	17 (2.3%)
Native American	4 (0.5%)	4 (0.5%)
Pacific Islander	15 (2.0%)	13 (1.7%)
Asian	145 (19.4%)	152 (20.3%)
Other/Unknown	153 (20.5%)	151 (20.2%)
Pre-Op COPD, n (%)	47 (6.3%)	50 (6.7%)	0.75
Pre-Op Dialysis, n(%)	43 (5.8%)	43 (5.8%)	1.00
Pre-Op Diabetes, n(%)	394 (52.7%)	396 (53.0%)	0.92
History of Atrial Fibrillation, n(%)	83 (11.1%)	98 (13.1%)	0.23
Pre-Op HTN, n(%)	606 (81.1%)	589 (78.8%)	0.27
History of Ventricular Tachycardia, n(%)	11 (1.5%)	20 (2.7%)	0.10
NYHA, n(%)			1.00
0	276 (36.9%)	275 (36.8%)
1	456 (61.0%)	457 (61.2%)
2	6 (0.8%)	6 (0.8%)
3	7 (0.9%)	7 (0.9%)
4	2 (0.3%)	2 (0.3%)
Post-Op LOS day (IQR)	7.0 (5.2, 11.0)	6.0 (4.9, 8.8)	<0.001
ICU LOS hours (IQR)	69.9 (40.8, 116.7)	54.0 (40.4, 97.0)	0.010
Post-Op Vent hours (IQR)	272.4 (22.2, 839.9)	23.5 (9.6, 122.6)	<0.001
Days to Urinary Catheter Removal (IQR)	2.4 (1.6, 3.9)	2.3 (1.6, 3.9)	0.82
Days to First Ambulation (IQR)	2.3 (1.6, 3.5)	1.6 (1.5, 2.6)	<0.001
Days to First Bowel Movement (IQR)	3.0 (2.0, 4.0)	2.0 (0.0, 3.0)	<0.001
Post-Op Ventilator Associated Pneumonia	37 (5.0%)	16 (2.1%)	0.003
30-day mortality	30 (4%)	25 (3.3%)	0.47
Post-Op Urinary Tract Infection	62 (8.3%)	27 (3.6%)	<0.001
Post-Op Wound Infection	3 (0.4%)	1 (0.1%)	0.32
Euroscore (IQR)	2.0 (1.0, 3.8)	1.6 (0.9, 3.4)	0.075

Propensity-Score Matched CABG/Valve Group. Values are presented as n (%) or median (interquartile range).